Related Experiment Video

Updated: Feb 26, 2026

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.5K

Dosimetric analysis reveals rapid clearance and low absorbed dose of [¹⁷⁷Lu]Lu-PSMA-617 in non-prostate cancers with

Fadi Khreish1,2,3, Florian Rosar4, Caroline Burgard4

  • 1Dept. of Nuclear Medicine, Saarland University, Homburg, Germany. fadi.khreish@klinikum-fulda.de.

EJNMMI Research
|February 24, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
DosimetryNon-prostate malignancyRLTRadioligand therapy[177Lu]Lu-PSMA-617

More Related Videos

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.6K
The Bioconjugation and Radiosynthesis of 89Zr-DFO-labeled Antibodies09:29

The Bioconjugation and Radiosynthesis of 89Zr-DFO-labeled Antibodies

Published on: February 12, 2015

18.3K

Related Concept Videos